| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2025 | Sep 18, 2025 | Revolution Medicines, Inc. | Chief Medical Officer | Sell | 41.3 | -2,160 | -2.39% | ✓ | $99K |
| Jun 16, 2025 | Jun 18, 2025 | Revolution Medicines, Inc. | Chief Medical Officer | Sell | 41.3 | -2,173 | -2.34% | ✓ | $86.6K |
| Jun 17, 2024 | Jun 20, 2024 | Revolution Medicines, Inc. | Chief Medical Officer | Sell | 42.5 | -5,589 | -7.31% | ✗ | $209K |
| Feb 1, 2023 | Feb 3, 2023 | Erasca, Inc. | Chief Medical Officer | Buy | 60.0 | +1,750 | 0.28% | ✗ | $7.2K |
| Feb 1, 2022 | Feb 3, 2022 | Erasca, Inc. | Chief Medical Officer | Buy | 61.3 | +1,562 | 0.50% | ✗ | $18.1K |